Abstract
In order to achieve a high efficacy in cancer therapies which use radiation and/or hyperthermia, it is necessary to study and understand two important signal transduction pathways which can depress cell survival signals and simultaneously enhance cell death signals. Recent progress in molecular biology has provided information about these molecules and the associated mechanisms involved in their signaling and functioning. Targeting therapies have thus been examined to look for those which can affect genes capable of inducing a high efficiency in killing cancer cells after exposures to radiation and/or hyperthermia therapies. Target genes which function in cell survival signal transduction pathways, DNA repair, and protein repair are of primary interest. In contrast, apoptosis- and necrosis-inducing factors have an important role in leading to cell death in response to therapies. In this review, results from recent research efforts in Nara University are discussed.
Keywords: p53, signal transduction, radiation, hyperthermia, cancer therapy
Current Signal Transduction Therapy
Title: Signal Transduction of Radiation and/or Hyperthermic Cancer Therapies
Volume: 5 Issue: 3
Author(s): Takeo Ohnishi and Akihisa Takahashi
Affiliation:
Keywords: p53, signal transduction, radiation, hyperthermia, cancer therapy
Abstract: In order to achieve a high efficacy in cancer therapies which use radiation and/or hyperthermia, it is necessary to study and understand two important signal transduction pathways which can depress cell survival signals and simultaneously enhance cell death signals. Recent progress in molecular biology has provided information about these molecules and the associated mechanisms involved in their signaling and functioning. Targeting therapies have thus been examined to look for those which can affect genes capable of inducing a high efficiency in killing cancer cells after exposures to radiation and/or hyperthermia therapies. Target genes which function in cell survival signal transduction pathways, DNA repair, and protein repair are of primary interest. In contrast, apoptosis- and necrosis-inducing factors have an important role in leading to cell death in response to therapies. In this review, results from recent research efforts in Nara University are discussed.
Export Options
About this article
Cite this article as:
Ohnishi Takeo and Takahashi Akihisa, Signal Transduction of Radiation and/or Hyperthermic Cancer Therapies, Current Signal Transduction Therapy 2010; 5 (3) . https://dx.doi.org/10.2174/157436210791920283
DOI https://dx.doi.org/10.2174/157436210791920283 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Uses of Melatonin: Evaluation of Human Trials
Current Medicinal Chemistry Estrogen Receptor Neurobiology and its Potential for Translation into Broad Spectrum Therapeutics for CNS Disorders
Current Molecular Pharmacology STAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment
Current Medicinal Chemistry Supplements, Diets and Other Complementary and Alternative Interventions in Adolescent Mental Health
Adolescent Psychiatry Integrating Qualitative and Quantitative Tools for the Detection and Identification of Lectins in Major Human Diseases
Protein & Peptide Letters Patent Selections:
Recent Patents on Biomarkers Current State of the Art of New Tubulin Inhibitors in the Clinic
Current Clinical Pharmacology Skin Cancers in Elderly Patients
Anti-Cancer Agents in Medicinal Chemistry CEBP Epigenetic Dysregulation as a Drug Target for the Treatment of Hematologic and Gynecologic Malignancies
Current Drug Targets Advances in Regulating Tumorigenicity and Metastasis of Cancer Through TrkB Signaling
Current Cancer Drug Targets Radiation Exposure of Anaesthetists Visualised by Real-time Dosimetry
Current Medical Imaging Receptor Tyrosine Kinase Kit and Gastrointestinal Stromal Tumours: An Overview
Current Medicinal Chemistry Development of personalized molecular therapy for acute myeloid leukemia
Current Pharmaceutical Biotechnology Unknown Primary Squamous Cell Carcinoma of the Head and Neck
Current Cancer Therapy Reviews Characterization of Stem-Like Cells Directly Isolated from Freshly Resected Laryngeal Squamous Cell Carcinoma Specimens
Current Stem Cell Research & Therapy Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution
Current Molecular Medicine COX-2 Selective Inhibitors, Carbonic Anhydrase Inhibition and Anticancer Properties of Sulfonamides Belonging to This Class of Pharmacological Agents
Mini-Reviews in Medicinal Chemistry Recent Developments in Patented DC-Based Immunotherapy for Various Malignancies
Recent Patents on Regenerative Medicine MicroRNAs in Cancer Therapy: From Bench to Bedside
Current Cancer Therapy Reviews Dendritic Cells and their Receptors in Antitumor Immune Response
Current Molecular Medicine